Chinese vaccine maker Sinovac, who developing the COVID-19 vaccine candidate called CoronaVac, says it has secured US$500 million in additional funding to rush out the drug for general use. – EPA pic, December 7, 2020. CHINESE pharmaceutical firm Sinovac Biotech has secured US$500 million (RM2.03 million) in extra funding to produce its Covid-19 vaccine, it said today, as the country races to roll out a jab for general use.Beijing has largely brought the virus under control, with only 281 active cases still receiving treatment, according to official figures.
apple developer enterprise account for rent
providing apple enterprise developer accounts for rent, rent your own enterprise account for app signing. with high quality, stable performance and affordable price.